Douglas Holtzman - Jul 29, 2022 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Stock symbol
ICVX
Transactions as of
Jul 29, 2022
Transactions value $
-$69,168
Form type
4
Date filed
8/2/2022, 09:42 PM
Previous filing
Feb 14, 2023
Next filing
Nov 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Sale -$4.16K -585 -0.19% $7.11 303K Jul 29, 2022 Direct F1, F2
transaction ICVX Common Stock Sale -$62K -9.34K -3.08% $6.64 294K Aug 1, 2022 Direct F3, F4
transaction ICVX Common Stock Sale -$3.04K -453 -0.15% $6.70 293K Aug 2, 2022 Direct F1, F5
transaction ICVX Common Stock Gift $0 -20K -47.13% $0.00 22.4K Feb 18, 2022 By Stanley Holtzman F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover the withholding taxes upon settlement of restricted stock units issued to the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Also includes the sale of 7,666 shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.38 to $7.17. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.460 to $6.865. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.